Astrana Health Operating Income Over Time
| ASTH Stock | 22.41 0.41 1.86% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Astrana Health Performance and Astrana Health Correlation. Is there potential for Health Care Providers & Services market expansion? Will Astrana introduce new products? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.98) | Earnings Share 0.19 | Revenue Per Share | Quarterly Revenue Growth 0.997 | Return On Assets |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Astrana Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Astrana Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Astrana Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Income Analysis
Compare Astrana Health and related stocks such as Select Medical Holdings, Mednax Inc, and National HealthCare Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SEM | 119.1 M | 310.7 M | 336.9 M | 301.4 M | 284.5 M | 274.8 M | 299.8 M | 355.9 M | 417.3 M | 471.9 M | 567.7 M | 713.8 M | 403.3 M | 554.9 M | 268.3 M | 308.6 M | 374 M |
| MD | 9.1 M | 355.4 M | 389.5 M | 452.1 M | 513 M | 557.9 M | 571.7 M | 480.1 M | 445.8 M | 171.8 M | 98.1 M | 202.9 M | 172.7 M | 7.3 M | (68.7 M) | (79 M) | (75.1 M) |
| NHC | 30.9 M | 78.9 M | 68.2 M | 72.1 M | 68 M | 67.1 M | 60.5 M | 54.1 M | 56.1 M | 49 M | 48.2 M | 50.9 M | 31.9 M | 57.1 M | 85.8 M | 98.6 M | 51.7 M |
| AVAH | 39 M | 39 M | 39 M | 39 M | 39 M | 39 M | 39 M | 39 M | 39 M | 39 M | (3.5 M) | (36.1 M) | (642.3 M) | 8.1 M | 139.8 M | 125.8 M | 132.1 M |
| ACHC | 8.8 M | (29.1 M) | 70.7 M | 123 M | 172.8 M | 320.8 M | 445.1 M | 437.9 M | 412.7 M | 661.6 M | 365.6 M | 414.5 M | 467.7 M | 506.6 M | 522.3 M | 600.6 M | 359.4 M |
| USPH | (300 K) | 35.9 M | 37.8 M | 38.8 M | 45.8 M | 47.3 M | 49.5 M | 54.7 M | 60.3 M | 67.4 M | 52.4 M | 70.6 M | 56.8 M | 52.1 M | 63.2 M | 72.7 M | 76.3 M |
| MNKD | (25.2 M) | (140.5 M) | (147 M) | (169.4 M) | (179.6 M) | (344.7 M) | 67.3 M | (108.2 M) | (76.6 M) | (44.6 M) | (47.9 M) | (47 M) | (64.1 M) | 8.7 M | 72.6 M | 83.5 M | 87.6 M |
| OMCL | (19.5 M) | 16.2 M | 27.1 M | 35.3 M | 49.6 M | 48.6 M | 6.5 M | 5.8 M | 44.4 M | 78.4 M | 35.5 M | 89.5 M | (2.3 M) | (34.9 M) | 337 K | 387.6 K | 368.2 K |
| HCSG | 2.2 M | 56.8 M | 67.3 M | 62.8 M | 30.1 M | 89.1 M | 117.8 M | 126.9 M | 100.2 M | 77.9 M | 108 M | 64.1 M | 43.8 M | 54.7 M | 53.3 M | 61.3 M | 40.4 M |
| LFST | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 15.4 M | (286.4 M) | (210.2 M) | (189.1 M) | (31.6 M) | (28.5 M) | (29.9 M) |
Astrana Health and related stocks such as Select Medical Holdings, Mednax Inc, and National HealthCare Operating Income description
Operating Income is the amount of profit realized from Astrana Health operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Astrana Health is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Astrana Health | ASTH |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 1668 S Garfield |
| Exchange | NASDAQ Exchange |
null 22.41
Check out Astrana Health Performance and Astrana Health Correlation. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Astrana Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.